Mr Blake Charles Mann, PT, DPT | |
1255 S State St Ste 7, Dover, DE 19901-6932 | |
(302) 734-0100 | |
Not Available |
Full Name | Mr Blake Charles Mann |
---|---|
Gender | Male |
Speciality | Physical Therapy |
Experience | 3 Years |
Location | 1255 S State St Ste 7, Dover, Delaware |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104493089 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | J1-0014376 (Delaware) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Performance Enhancement Professionals Llc | 8527287036 | 7 |
News Archive
Northwestern Medicine- scientists have successfully tested a nontoxic therapy that suppresses Lupus in blood samples of people with the autoimmune disease.
Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced that the company's Surefire Infusion System will be used in the development of the first clinically viable microcatheter-based, minimally invasive treatment for obesity as an alternative to bariatric surgery.
Substituting one to two servings of animal proteins with plant proteins every day could lead to a small reduction in the three main cholesterol markers for cardiovascular disease prevention, a new study suggests.
Researchers at Dana-Farber/Children's Hospital Cancer Center have devised a strategy to directly activate a natural "death" protein, triggering the self-destruction of cells. They say the development could represent a new paradigm for designing cancer drugs.
› Verified 8 days ago
Provider Name | Performance Enhancement Professionals Llc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1417361197 PECOS PAC ID: 8527287036 Enrollment ID: O20140916001197 |
News Archive
Northwestern Medicine- scientists have successfully tested a nontoxic therapy that suppresses Lupus in blood samples of people with the autoimmune disease.
Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced that the company's Surefire Infusion System will be used in the development of the first clinically viable microcatheter-based, minimally invasive treatment for obesity as an alternative to bariatric surgery.
Substituting one to two servings of animal proteins with plant proteins every day could lead to a small reduction in the three main cholesterol markers for cardiovascular disease prevention, a new study suggests.
Researchers at Dana-Farber/Children's Hospital Cancer Center have devised a strategy to directly activate a natural "death" protein, triggering the self-destruction of cells. They say the development could represent a new paradigm for designing cancer drugs.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Blake Charles Mann, PT, DPT 114 S Spinnaker Ln, Milton, DE 19968-1538 Ph: (302) 500-2294 | Mr Blake Charles Mann, PT, DPT 1255 S State St Ste 7, Dover, DE 19901-6932 Ph: (302) 734-0100 |
News Archive
Northwestern Medicine- scientists have successfully tested a nontoxic therapy that suppresses Lupus in blood samples of people with the autoimmune disease.
Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced that the company's Surefire Infusion System will be used in the development of the first clinically viable microcatheter-based, minimally invasive treatment for obesity as an alternative to bariatric surgery.
Substituting one to two servings of animal proteins with plant proteins every day could lead to a small reduction in the three main cholesterol markers for cardiovascular disease prevention, a new study suggests.
Researchers at Dana-Farber/Children's Hospital Cancer Center have devised a strategy to directly activate a natural "death" protein, triggering the self-destruction of cells. They say the development could represent a new paradigm for designing cancer drugs.
› Verified 8 days ago
Adrianne Greene, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1288 S Governors Ave, Dover, DE 19904 Phone: 302-677-0100 Fax: 302-677-0267 | |
Ms. Amy Kathryn Tullis, PT, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 97 Commerce Way, Suite 101, Dover, DE 19904 Phone: 302-734-8000 | |
Jihwan Jeong, Physical Therapist Medicare: Medicare Enrolled Practice Location: 1288 S Governors Ave, Dover, DE 19904 Phone: 302-677-0100 | |
Matthew Vassalotti, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1288 S Governors Ave, Dover, DE 19904 Phone: 302-677-0100 Fax: 302-677-0267 | |
Kathy Tompkins, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 945 Forest St, Dover, DE 19904 Phone: 302-672-1500 | |
Christine Marie Reynolds, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1203 Walker Rd, Dover, DE 19904 Phone: 302-735-8800 | |
Katherine Marie Monahan, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1288 S Governors Ave, Dover, DE 19904 Phone: 302-677-0100 |